Navigation Links
First Patients Enrolled in Phase II Trial With Intravenous Iclaprim in HAP/VAP/HCAP
Date:12/12/2007

setting. AR-709 exhibited potent activity against a large panel of pneumococcal clinical isolates including those resistant to currently used drugs. Promising results of "first-in-man" studies with AR-709 were published in March 2007.

An additional compound, AR-2474, has achieved in vivo proof of concept. AR-2474 has been shown to be highly effective in eradicating pathogens in preclinical models of skin infection and nasal carriage.

Apart from the antibiotic programmes, Arpida has an innovative antifungal therapy (TLT) which is about to enter Phase III clinical trials in Europe, targeting onychomycosis.

Moreover, the company has several other leads in optimisation and additional discovery programmes derived from its own discovery platform at various research stages.

This press release contains specific forward-looking statements, e.g. statements including terms like believe, assume, expect or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties readers should not place undue reliance on forward-looking statements. The company assumes no responsibility to update forward-looking statements or to adapt them to future events or developments.

Arpida contacts:

Dr Khalid Islam, President and CEO Tel: +41-61-417-96-60

Harry Welten, MBA, CFO and Senior Vice President Tel: +41-61-417-96-65

Paul Verbraeken, Head of Corporate Communications Tel: +41-61-417-96-83


'/>"/>
SOURCE Arpida Ltd
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
3. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
4. Genmab Announces 2007 First Half Year Results
5. Pharsight Achieves First License Sale for Public-Source Database
6. Novare Announces First Ever Single Port Laparoscopic Kidney Removal (Nephrectomy) Using RealHand(TM) HD Instruments
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. China Medical Technologies Reports First Quarter Financial Results
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
11. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2008)...-FirstCall/ -- PharmAthene, Inc.,(NYSE Alternext ...,countermeasures against biological and chemical t...eement with Medison Pharma Ltd., to commercialize ...need for advanced medical countermeasures to comba...r chemical weapons is a significant global,concer...
(Date:11/19/2008)...swire-FirstCall/ -- American,HealthChoice, Inc. (...ce.com , a,medical services company with medical ...ounce the first sales of the U.S. FDA approved Omn...at detects patterns of abnormality within,the hum...revention and,treatment. , "Physicians pur...
(Date:11/19/2008)...ire-FirstCall/ -- Jazz Pharmaceuticals,Inc. (Nas...corporate presentation,planned for today at the L...rence due to the proximity of the release of preli...otal clinical trial of JZP-6 (sodium oxybate) for,...ny anticipates that it will release the preliminar...
(Date:11/19/2008)...r Tengion Neo-Bladder(TM) Franchise , , EAS...Inc. , a clinical stage regenerative medicine comp...eo-tissues, today announced that it has completed ...ing a total of approximately $21 million in additi...stitutional equity investor base along with new in...
Breaking Biology Technology:PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel 2PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel 3PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel 4American HealthChoice Announces the First Sales of the OmniBody Scan 2Tengion Announces Second Closing of Series C Financing 2Tengion Announces Second Closing of Series C Financing 3
..., , , , RohanA.Thakur, AndrewW. Guz... , , , , Ion Trap Analysis ,...n be acquired using , a Thermo Finnigan LCQ... trap mass spectrometer., , , , ... , , Two important considerations in many...
..., , , , Mark Churchill 1 , Mark Har...d 2 , , 1 Thermo Finnigan, Staffor... Hempstead, HP2 7GE, UK; , 2 Aker Unive...ping Analysis,Trondheimsveien, , N-0514, Os... Monitoring Clenbuterol in Humans , ,...
... , , , For transfection of cells wit..., , Features and benefits , , , ...ent transfection of siRNA for effective gene silen... Ready-to-use reagent , Tested for abs... , Principle , , , , , ,...
... , , , QIAshredder spin columns are... of cell and tissue lysates. , , , ... Format: , Mini spin columns, ...source: , Animal or human cell or tissu...ates, white blood cell lysates, , ...
Other Biology Technology:Enhancing Ruggedness and Full-Scan MS Sensitivity Using Ion Sweep , Technology 2Enhancing Ruggedness and Full-Scan MS Sensitivity Using Ion Sweep , Technology 3Enhancing Ruggedness and Full-Scan MS Sensitivity Using Ion Sweep , Technology 4Enhancing Ruggedness and Full-Scan MS Sensitivity Using Ion Sweep , Technology 5Enhancing Ruggedness and Full-Scan MS Sensitivity Using Ion Sweep , Technology 6Enhancing Ruggedness and Full-Scan MS Sensitivity Using Ion Sweep , Technology 7Enhancing Ruggedness and Full-Scan MS Sensitivity Using Ion Sweep , Technology 8Improved Quantitative Selectivity of Clenbuterol in Human Urine using , High Resolution on the TSQ Quantum Mass Spectrometer 2Improved Quantitative Selectivity of Clenbuterol in Human Urine using , High Resolution on the TSQ Quantum Mass Spectrometer 3Improved Quantitative Selectivity of Clenbuterol in Human Urine using , High Resolution on the TSQ Quantum Mass Spectrometer 4Improved Quantitative Selectivity of Clenbuterol in Human Urine using , High Resolution on the TSQ Quantum Mass Spectrometer 5TransMessenger Transfection Reagent 2TransMessenger Transfection Reagent 3QIAshredder Homogenizer 2
(Date:11/19/2008)...Monday awarded $66.9 million to the Big Sky Carbon...sity to fund a project that will inject a million ...er beneath southwestern Wyoming. , The award mar...r the Big Sky partnership, which is based at MSU. ...l stay on the MSU campus to pay for the university...
(Date:11/19/2008)...researchers led by investigators at the Albert Ein...s determined that certain commonly-prescribed medi...reasing the frequency of migraine attacks. This im...ibe migraine medicines. , In a recent article pu...d study of more than 8,000 migraine sufferers nati...
(Date:11/19/2008)...of Central Florida professor show early promise fo...rofessor James Turkson,s compounds disrupt the for... on mice. The compounds, S3I-201 and S3I-M2001, b... researchers have observed no negative side effect...Turkson said. "They,ve worked very well in mice, a...
(Date:11/18/2008)...ound the Thanksgiving table this year will enjoy a...cale" breeding cranberries. , While this year,s...no different than servings of yore, a new cranberr...d improve fruit quality for the annual fall feast....round demand for juices, fruit drinks, and "craisi...
Breaking Biology News(10 mins):Montana State partnership receives $66.9M for carbon sequestration 2Montana State partnership receives $66.9M for carbon sequestration 3Overuse of narcotics and barbiturates may make migraine worse 2Two new compounds show promise for eliminating breast cancer tumors 2Favorite Thanksgiving dish gets 'upscale' breeding 2Symmetry Medical Reports Third Quarter 2008 Financial Results 29595 1Symmetry Medical Reports Third Quarter 2008 Financial Results 29595 2Symmetry Medical Reports Third Quarter 2008 Financial Results 29595 3Symmetry Medical Reports Third Quarter 2008 Financial Results 29595 4Symmetry Medical Reports Third Quarter 2008 Financial Results 29595 5Symmetry Medical Reports Third Quarter 2008 Financial Results 29595 6Symmetry Medical Reports Third Quarter 2008 Financial Results 29595 7Symmetry Medical Reports Third Quarter 2008 Financial Results 29595 8Symmetry Medical Reports Third Quarter 2008 Financial Results 29595 9Anpath Group Inc Expands International Distribution With Minntech Corporation 29591 1Anpath Group Inc Expands International Distribution With Minntech Corporation 29591 2Anpath Group Inc Expands International Distribution With Minntech Corporation 29591 3Chemical Engineering Conference Highlights Energy Biomedicine Pharmaceuticals Sustainability and Centennial 9125 1Chemical Engineering Conference Highlights Energy Biomedicine Pharmaceuticals Sustainability and Centennial 9125 2SwiftMD to Provide Telemedicine Services to New Montana Development 29587 1SwiftMD to Provide Telemedicine Services to New Montana Development 29587 2SwiftMD to Provide Telemedicine Services to New Montana Development 29587 3
...,discovered a form of blue-green algae that lives ...ar-infrared light for photosynthesis,according to...n of the,Proceedings of the National Academy of Sc...s unique because it is able to live,on its own," s...ed,samples containing the organism while studying ...
...ctiveness of treating tumors by combining agents t...cells to these agents. , The research, led by Geor...cinnati,s (UC) Genome Research Institute, and Heid...rch, appears in the March 25, 2005, issue of the j... Fumagalli, PhD, began this research while working...
...uthwestern Medical Center sheds light on the mecha...fenses and may aid in the development of more effe...uses, as well as the flu and the common cold. , I...l of Virology and currently available online, UT S...gene, called RIG-I, turns on a cascade of host imm...
...for malaria vaccine development, scientists have u...es to trace how malaria parasites,evolve on a mole...nsect,vectors.,That focus on the parasites, comple...n different genes switch on and off as the pathoge...s. In turn, that,molecular-level data may benefit ...
Other Biology News:Scientists discover unique microbe in California's largest lake 2Scientists discover unique microbe in California's largest lake 3Scientists discover unique microbe in California's largest lake 4Scientists discover unique microbe in California's largest lake 5Researchers add new tool to tumor-treatment arsenal 2Studies reveal methods viruses use to sidestep immune system 2Studies reveal methods viruses use to sidestep immune system 3Scientists reveal molecular secrets of the malaria parasite 2Scientists reveal molecular secrets of the malaria parasite 3